What is the best angiotensin-converting enzyme (ACE) inhibitor for a diabetic adult with proteinuria?

Best ACE Inhibitor for Diabetic Proteinuria

Any ACE inhibitor from the class is appropriate for diabetic proteinuria, as guidelines recommend ACE inhibitors or ARBs as interchangeable first-line agents without specifying superiority of individual drugs within the class. 1, 2, 3

Class-Level Recommendation

The evidence supports using ACE inhibitors as a drug class rather than recommending a specific agent:

• Canadian and KDOQI guidelines explicitly state that ACE inhibitors and ARBs have interchangeable benefits for diabetic kidney disease, assuming a class effect across these agents 1, 4
• Guidelines recommend "an ACE inhibitor or ARB" without distinguishing between individual drugs 5, 3
• The 2022 KDIGO guideline recommends titrating whichever ACE inhibitor is chosen to the highest approved dose that is tolerated 3

Evidence-Based Considerations

Type 1 vs Type 2 Diabetes

• Type 1 diabetes with proteinuria: ACE inhibitors have stronger historical evidence, with captopril specifically studied in landmark trials showing reduction in doubling of serum creatinine, progression to kidney failure, and death 1, 2
• Type 2 diabetes with proteinuria: Both ACE inhibitors and ARBs show similar efficacy, though ARBs have been more extensively studied in this population 1, 2

Comparative Data on Specific Agents

The limited head-to-head evidence suggests:

• Captopril may be inferior among ACE inhibitors based on a 2017 retrospective study showing poorer renal outcomes (HR 1.42) and higher mortality (HR 1.25) compared to other ACE inhibitors 6
• Perindopril demonstrated effectiveness in reducing albuminuria more than placebo or nifedipine in normotensive diabetic patients 7
• Enalapril (10-20 mg daily) showed benefit in preventing progression from microalbuminuria to macroalbuminuria 1

Practical Algorithm

For Type 1 Diabetes with Proteinuria:

1. Start any ACE inhibitor except captopril (based on comparative data)
2. Common choices: enalapril 10-20 mg daily, lisinopril 10-40 mg daily, or ramipril 2.5-10 mg daily
3. Titrate to maximum tolerated dose

For Type 2 Diabetes with Proteinuria:

1. Either ACE inhibitor or ARB is appropriate
2. If choosing ACE inhibitor: avoid captopril; use enalapril, lisinopril, or ramipril
3. Titrate to maximum tolerated dose

Critical Monitoring Requirements

• Check serum creatinine and potassium within 2-4 weeks of initiation or dose increase 3, 8
• Continue therapy unless creatinine rises >30% within 4 weeks of starting treatment 3
• Monitor for hyperkalemia; manage with dietary potassium restriction and other measures before discontinuing the ACE inhibitor 3

Important Caveats

Do NOT combine ACE inhibitors with ARBs - this increases risk of hyperkalemia and acute kidney injury without additional benefit, as demonstrated in ONTARGET and VA NEPHRON-D trials 5, 9

The evidence does not support one specific ACE inhibitor as definitively superior, though avoiding captopril may be prudent based on the single comparative study showing inferior outcomes 6. The key is selecting any ACE inhibitor, titrating to maximum tolerated dose, and ensuring appropriate monitoring.